SCORR Marketing, the full-service marketing and communications firm in the health science industry, and the Conference Forum, the presenter of strategic-level life science conferences, will collaborate on the 2020 Clinical Research as a Care Option (CRAACO) conference. The Conference Forum will include key initiatives and thought leaders from the Bridging Clinical Research & Clinical Health Care Collaborative at its CRAACO conference.
“We started the Bridging Collaborative in 2018 to bring all stakeholders together to address the gap between clinical research and health care,” said Cinda Orr, CEO at SCORR. “Moving these discussions to CRAACO means the momentum of the Bridging Collaborative will continue as we persist in exploring ways to put patients at the center of research and care.”
Although the Bridging Collaborative is changing, its key areas of focus will continue to be discussed through the CRAACO conference.
“While CRAACO approaches clinical research as a care option from a different viewpoint, we expect this collaboration will make our event stronger by bringing more voices to the conversation,” said Valerie Bowling, executive director of the Conference Forum. “This enhances our ability to facilitate meaningful discussions that ultimately benefit patients.”
CRAACO will be April 27–28, 2020, in Raleigh-Durham, NC.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.